| 邱一真.辛伐他汀联合参麦治疗高血脂症的疗效观察[J].实用中西医结合临床,2010,(6):9-10 |
| 辛伐他汀联合参麦治疗高血脂症的疗效观察 |
|
| |
| DOI： |
| 中文关键词: 高血脂 辛伐他汀 参麦注射液 超敏C反应蛋白 |
| 英文关键词: Hyperlipidemia Simastatin Shenmai hs-CRP |
| 基金项目: |
|
| 摘要点击次数: 566 |
| 全文下载次数: 252 |
| 中文摘要: |
| 目的：观察辛伐他汀联合参麦治疗高血脂症的临床疗效。方法：168例高血脂症患者随机分为治疗组和对照组，两组均采用常规辛伐他汀治疗，治疗组加用参麦注射液40mL静脉输注，每日1次；4周后测定血浆总胆固醇（TC）、甘油三酯（TG）、高密度脂蛋白胆固醇（HDL-C）、低密度脂蛋白胆固醇（LDL-C）和高敏C反应蛋白（hs-CRP）。结果：在治疗后第4周，治疗组与对照组相比较，TC、LDL-C和 CRP明显下降，HDL-C升高，差异显著，均具有统计学意义(P <0.05)。结论：辛伐他汀联合参麦治疗高血脂效果更明显，可更有效降低hs-CRP水平。 |
| 英文摘要: |
| Objective: To evaluate the clinical therapeutic effect of combination simastatin and shenmai in patients with hyperlipidemia .Methods:168 patients with hyperlipidemia were randomly divided into treatment group and control group.All patients were given regular simastatin treatment.In treatment group,40mL shenmai injection,ivgtt，once a day for 4 weeks.TC、HDL-C、LDL-C and CRP were determined after 4 weeks.Results:Comparised treatment group with control group , TC、LDL-C and hs-CRP were decreased, HDL-C was increased,there were significant differences (P <0.05).Conclusion: simastatin combinated shenmai was more efffective for hyperlipidemia and decreased hs-CRP in plasma blood. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
